MX376367B - Activacion del factor x. - Google Patents

Activacion del factor x.

Info

Publication number
MX376367B
MX376367B MX2017001929A MX2017001929A MX376367B MX 376367 B MX376367 B MX 376367B MX 2017001929 A MX2017001929 A MX 2017001929A MX 2017001929 A MX2017001929 A MX 2017001929A MX 376367 B MX376367 B MX 376367B
Authority
MX
Mexico
Prior art keywords
factor
activation
systems
methods
relates
Prior art date
Application number
MX2017001929A
Other languages
English (en)
Other versions
MX2017001929A (es
Inventor
Christian Fiedler
Emst Bohm
Franziska Horling
Meinhard Hasslacher
Dockal Michael
Thomas Gatternig
Original Assignee
Takeda Pharmaceuticals Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co
Publication of MX2017001929A publication Critical patent/MX2017001929A/es
Publication of MX376367B publication Critical patent/MX376367B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6432—Coagulation factor Xa (3.4.21.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21006—Coagulation factor Xa (3.4.21.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se refiere a métodos y sistemas para activar el Factor X.
MX2017001929A 2014-08-12 2015-08-12 Activacion del factor x. MX376367B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462036402P 2014-08-12 2014-08-12
PCT/US2015/044863 WO2016025601A1 (en) 2014-08-12 2015-08-12 Factor x activation

Publications (2)

Publication Number Publication Date
MX2017001929A MX2017001929A (es) 2017-06-30
MX376367B true MX376367B (es) 2025-03-07

Family

ID=54062803

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017001929A MX376367B (es) 2014-08-12 2015-08-12 Activacion del factor x.

Country Status (10)

Country Link
US (1) US10036002B2 (es)
EP (1) EP3180355B1 (es)
JP (2) JP6791842B2 (es)
CN (1) CN107109391B (es)
AR (1) AR102331A1 (es)
AU (1) AU2015301712B8 (es)
ES (1) ES2752177T3 (es)
MX (1) MX376367B (es)
TW (1) TWI684599B (es)
WO (1) WO2016025601A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3590528A1 (en) * 2018-07-06 2020-01-08 Octapharma AG Fx activation process and its use in the preparation of a fxa composition

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19531637A1 (de) * 1995-08-28 1997-03-06 Immuno Ag Pharmazeutische Zusammensetzung zur Behandlung von Blutgerinnungsstörugnen, Verfahren zur Herstellung derselben und deren Verwendung
DE19710190A1 (de) * 1997-03-12 1998-09-17 Immuno Ag Aktivierter Vitamin K-abhängiger Blutfaktor und Verfahren zu dessen Herstellung
JP5306597B2 (ja) * 2003-07-01 2013-10-02 ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト 第ｖｉｉ因子ポリペプチドの液体水性薬学的組成物
JP2007055899A (ja) * 2003-10-27 2007-03-08 Chemo Sero Therapeut Res Inst 血液凝固第ｘ因子を主剤とする血液凝固異常に基づく疾患の治療・予防用医薬組成物
GB0710321D0 (en) * 2007-05-30 2007-07-11 Nhs Blood & Transplant Method
ES2908920T3 (es) * 2011-10-14 2022-05-04 Takeda Pharmaceuticals Co Purificación de proteínas mediante cromatografía de intercambio aniónico
AU2012322949B2 (en) * 2011-10-14 2015-07-02 Takeda Pharmaceutical Company Limited Protein purification by anion exchange chromatography
DK2970376T3 (en) * 2013-03-15 2018-07-02 Baxalta Inc PURIFICATION PROCEDURE FOR VITAMIN K-DEPENDENT PROTEINS BY ANION EXCHANGE CHROMATOGRAPHY

Also Published As

Publication number Publication date
CN107109391B (zh) 2021-04-13
ES2752177T3 (es) 2020-04-03
WO2016025601A1 (en) 2016-02-18
AR102331A1 (es) 2017-02-22
AU2015301712A8 (en) 2020-04-16
AU2015301712B2 (en) 2020-03-26
JP2020156505A (ja) 2020-10-01
MX2017001929A (es) 2017-06-30
TW201613957A (en) 2016-04-16
TWI684599B (zh) 2020-02-11
US20160046922A1 (en) 2016-02-18
EP3180355A1 (en) 2017-06-21
JP2017526669A (ja) 2017-09-14
JP6791842B2 (ja) 2020-11-25
AU2015301712B8 (en) 2020-04-16
CN107109391A (zh) 2017-08-29
EP3180355B1 (en) 2019-07-31
AU2015301712A1 (en) 2017-03-23
US10036002B2 (en) 2018-07-31

Similar Documents

Publication Publication Date Title
ECSP18008905A (es) Tricíclicos sustituidos y método para usarlos.
ECSP17029371A (es) Dihidropirrolopiridinas inhibidoras de ror-gamma
DK3560954T3 (da) Modificeret j-kæde
DK3135609T3 (da) Artikeltransportanlæg
FI20165624A (fi) Kaasunsyöttöjärjestelmä
IN2015DE00625A (es)
MY165760A (en) Absorbent article
ECSP17014972A (es) Compuestos de azetidiniloxifenilpirrolidina
MX386150B (es) Tasimelteon para tratar el síndrome de smith-magenis.
DK2937593T3 (da) Gastrykfjeder
DK3412700T3 (da) Forbindelser
UY36306A (es) Sintesis de ent-progesterona e intermediarios de la misma
CL2016002535A1 (es) Sistemas y métodos de sellado para miembros alargados
MX376367B (es) Activacion del factor x.
LT3200784T (lt) Smulkiaplokštės neuropatijos gydymas
TN2014000388A1 (fr) منظومة فيزيائية متجانسة كهربائية ميكانيكية مغناطيسية لتوليد الطاقة الكهربائية الحرة الايكولوجية المضاعفة
TN2014000354A1 (fr) جهاز مبتكر لتلقيح النخيل
GT201400039S (es) Diseño de bici-motocicleta
DK3032283T3 (da) Tryktolerant seismisk kilde
TN2014000468A1 (fr) اختراع الة للف شباك مراكب الصيد البحري و تسهيل تحويلها من المركب الى رصيف الميناء ثم ارجاعها للمركب بعد القيام بعملية ترقيعها
TN2014000355A1 (fr) طريقة مبتكرة لتوفير الاضاءة العامة و المنزلية
TH1501005556A (th) วิธีการและระบบสำหรับออกแบบสินค้า
DOS2014000289S (es) Mesas
TN2014000377A1 (fr) طائرة كهربائية كاتمة للصوت
TH1601000862A (th) ระบบและวิธีการสำหรับการผลิตชิ้นส่วนเพื่อความปลอดภัยแบบแยกความเฉพาะ

Legal Events

Date Code Title Description
FG Grant or registration
PD Change of proprietorship

Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED